株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

呼吸器疾患検査市場:世界の産業分析、規模、シェア、成長率、動向、予測 (2014年〜2022年)

Respiratory disease Testing Market (By Tests - Imaging, Spirometry, Peak Flow, Blood Gas, Lung Volume); (By End-User - Hospitals, Physician Offices & Clinical Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

発行 Transparency Market Research 商品コード 331352
出版日 ページ情報 英文 119 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
呼吸器疾患検査市場:世界の産業分析、規模、シェア、成長率、動向、予測 (2014年〜2022年) Respiratory disease Testing Market (By Tests - Imaging, Spirometry, Peak Flow, Blood Gas, Lung Volume); (By End-User - Hospitals, Physician Offices & Clinical Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022
出版日: 2015年05月19日 ページ情報: 英文 119 Pages
概要

当レポートでは、世界の呼吸器疾患検査市場について調査し、検査・エンドユーザー・地域別の市場規模・予測を提供しており、市場の戦略分析、市場戦略、および主要企業のプロファイルなどをまとめています。

第1章 序文

第2章 エグゼクティブサマリー

第3章 市場概要

  • 概要
  • バリューチェーン分析
  • 市場促進因子
  • 市場阻害因子
  • 市場機会
  • 規制の枠組み
  • ポーターのファイブフォース分析
  • 市場の魅力度分析:地域別

第4章 世界の呼吸器疾患検査市場:試験別

  • 概要
  • 画像検査
  • 肺活量測定
  • ピークフロー検査
  • 血液ガス検査
  • 肺気量検査
  • その他の検査 (運動、ガス交換、気管支鏡検査、胸腔鏡検査、ほか)

第5章 世界の呼吸器疾患検査市場:エンドユーザー別

  • 概要
  • 病院
  • 診療所
  • 臨床ラボ

第6章 世界の呼吸器疾患検査市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・北アフリカ (MENA)
  • その他 (RoW)

第7章 提言

  • 成功に向けた市場戦略

第8章 企業プロファイル

  • CareFusion Corporation
  • Carestream Health, Inc.
  • COSMED
  • Futuremed America, Inc.
  • GE Healthcare
  • MGC Diagnostics Corporation
  • ndd Medical Technologies, Inc.
  • 日本光電
  • Perkin Elmer, Inc.
  • Philips Healthcare
  • SDI Diagnostics
  • Siemens Healthcare
  • Smiths Medical

図表リスト

目次

Respiratory disease tests are required for the diagnosis of any chronic or acute respiratory disorder. The diagnosis of respiratory function is done either by understanding the anatomy of the respiratory organs, or by determining the respiratory capabilities of the lungs. A majority of respiratory tests are designed either to identify obstructions in the respiratory tract, or to observe the efficiency of the lungs in exchanging respiratory gases. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. This research report on the respiratory disease testing market explains various advancements in this market and analyzes the global respiratory disease testing market based on device type, end-user, and geographic regions. This report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global respiratory disease testing market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter's Five Forces analysis and key players' market share analysis in 2013 in the respiratory disease testing market. The research report also provides value chain (distribution) analysis from the supplier of the raw material to the end-users (hospital, physician offices, and clinical laboratories).

Based on type of test, the global respiratory disease testing market has been segmented into imaging test, spirometry, peak flow test, blood gas test, lung volume test, and other tests. The market for these tests has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each technology has been provided for the period from 2012 to 2022. The report on the respiratory disease testing market also provides % compound annual growth rate (CAGR) for each of the market segment and sub-segment mentioned above for the forecast period from 2014 to 2022, considering 2013 as the base year.

Based on end-user, the global respiratory disease testing market has been segmented into hospitals, physician offices, and clinical laboratories. The market for these end-users of respiratory disease testing has been extensively analyzed based on installation rate and utilization of the devices in hospitals, physician offices, and clinical laboratories. The market size and forecast in terms of USD million for each segment has been provided for the period from 2012 to 2022. The report on the respiratory disease testing market also provides % compound annual growth rate (CAGR) for each market segment and sub-segment for the forecast period from 2014 to 2022, considering 2013 as the base year.

Geographically, the respiratory disease testing market has been categorized into North America, Europe, Asia-Pacific, Latin America, Middle East North Africa, and Rest of the World (RoW). The market size and forecast for each of these regions have been provided for the period from 2012 to 2022 along with CAGR (%) for the forecast period from 2014 to 2022. The research study also incorporates the competitive scenario of major players in these regions.

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the respiratory disease testing market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Philips Healthcare, GE Healthcare, CareFusion Corporation, Cosmed, ndd Medical Technologies, Inc., and SDI Diagnostics.

The global respiratory disease testing market is segmented as follows:

Global Respiratory Disease Testing Market, by Test

  • Imaging Tests
  • Spirometry Tests
  • Peak Flow Tests
  • Blood Gas Tests
  • Lung Volume Tests
  • Other Tests

Global Respiratory Disease Testing Market, by End-user

  • Hospitals
  • Physician Offices
  • Clinical Laboratories

Global Respiratory Disease Testing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific (APAC)
    • Japan
    • China
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East North Africa (MENA)
    • Saudi Arabia
    • UAE
    • Rest of MENA
    • Rest of the World

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Secondary Research
    • 1.3.2 Primary Research
    • 1.3.3 Models
    • 1.3.4 Assumptions
  • 1.4 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Respiratory Disease Testing Market (2013 & 2022)
  • 2.2 Global Respiratory Disease Testing Market, by Tests, 2013 (USD Million)
  • 2.3 Comparative Analysis: Global Respiratory Disease Testing Market, by Geography, 2013 and 2022 (Value %)

Chapter 3 Market Overview

  • 3.1 Overview
  • 3.2 Value Chain Analysis
  • 3.3 Market Drivers
    • 3.3.1 Increasing prevalence of respiratory diseases
    • 3.3.2 Growing geriatric population propels the uptake of respiratory disease testing products
    • 3.3.3 Technological advancements boost demand for respiratory disease testing products
  • 3.4 Restraints
    • 3.4.1 Low adoption rate of digital radiography systems and advanced spirometers
  • 3.5 Opportunities
    • 3.5.1 Capitalizing on the potential presented by emerging markets in Asia-Pacific
  • 3.6 Regulatory Framework
  • 3.7 Porter's Five Forces Analysis: Global Respiratory Disease Testing Market
    • 3.7.1 Bargaining power of suppliers
    • 3.7.2 Bargaining power of buyers
    • 3.7.3 Threat of substitutes
    • 3.7.4 Threat of new entrants
    • 3.7.5 Competitive rivalry
  • 3.8 Market Attractiveness Analysis: Global Respiratory Disease Testing Market, by Geography
    • 3.9.1 Market Share Analysis, by Key Players: Global Respiratory Disease Testing Market, 2013 (Value %)

Chapter 4 Global Respiratory Disease Testing Market, by Tests

  • 4.1 Overview
    • 4.1.1 Global Respiratory Disease Testing Market Revenue, by Tests, 2012 - 2022 (USD Million)
  • 4.2 Imaging Tests
    • 4.2.1 Global Imaging Test Market Revenue, 2012 - 2022 (USD Million)
  • 4.3 Spirometry
    • 4.3.1 Global Spirometry Test Market Revenue, 2012 - 2022 (USD Million)
  • 4.4 Peak Flow Test
    • 4.4.1 Global Peak Flow Test Market Revenue, 2012 - 2022 (USD Million)
  • 4.5 Blood Gas Test
    • 4.5.1 Global Blood Gas Test Market Revenue, 2012 - 2022 (USD Million)
  • 4.6 Lung Volume Test
    • 4.6.1 Global Lung Volume Test Market Revenue, 2012 - 2022 (USD Million)
  • 4.7 Other Tests (Exercise, Gas transfer, Bronchoscopy, Thoracoscopy, etc.)
    • 4.7.1 Global Other Tests Market Revenue, 2012 - 2022 (USD Million)

Chapter 5 Global Respiratory Disease Testing Market, by End-User

  • 5.1 Overview
    • 5.1.1 Global Respiratory Disease Testing Market Revenue, by End-User, 2012 - 2022 (USD Million)
  • 5.2 Hospitals
    • 5.2.1 Global Hospitals End-User Market Revenue, 2012 - 2022 (USD Million)
  • 5.3 Physician Offices
    • 5.3.1 Global Physician Offices End-User Market Revenue, 2012 - 2022 (USD Million)
  • 5.4 Clinical Laboratories
    • 5.4.1 Global Clinical Laboratories End-User Market Revenue, 2012 - 2022 (USD Million)

Chapter 6 Global Respiratory Disease Testing Market, by Geography

  • 6.1 Overview
    • 6.1.1 Global Respiratory Disease Testing Market Revenue, by Geography, 2012 - 2022 (USD Million)
  • 6.2 North America
    • 6.2.1 North America Respiratory Disease Testing Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Canada Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Respiratory Disease Testing Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 6.3.2 U.K.
      • 6.3.2.1 U.K. Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Germany Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
    • 6.3.4 Rest of Europe
      • 6.3.4.1 Rest of Europe Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Respiratory Disease Testing Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 6.4.2 Japan
      • 6.4.2.1 Japan Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
    • 6.4.3 China
      • 6.4.3.1 China Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
    • 6.4.4 Rest of Asia Pacific
      • 6.4.4.1 Rest of APAC Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America Respiratory Disease Testing Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
    • 6.5.4 Rest of Latin America
      • 6.5.4.1 Rest of LATAM Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • 6.6 Middle East North Africa (MENA)
    • 6.6.1 Middle East North Africa Respiratory Disease Testing Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 6.6.2 Saudi Arabia
      • 6.6.2.1 Saudi Arabia Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
    • 6.6.3 UAE
      • 6.6.3.1 UAE Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
    • 6.6.4 Rest of MENA
      • 6.6.4.1 Rest of MENA Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • 6.7 Rest of the World
    • 6.7.1 Rest of the World Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)

Chapter 7 Recommendations

  • 7.1 Market Strategy for Success
    • 7.1.1 Mergers and acquisitions for market expansion
    • 7.1.2 Emphasize on increasing affordability of modern imaging systems
    • 7.1.3 Investing in emerging markets

Chapter 8 Company Profiles

  • 8.1 CareFusion Corporation
    • 8.1.1 Company Overview
    • 8.1.2 Financial Overview
    • 8.1.3 Product Portfolio
    • 8.1.4 Business Strategies
    • 8.1.5 Recent Developments
  • 8.2 Carestream Health, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Overview
    • 8.2.3 Product portfolio
    • 8.2.4 Business Strategies
    • 8.2.5 Recent Developments
  • 8.3 COSMED
    • 8.3.1 Company Overview
    • 8.3.2 Financial Overview
    • 8.3.3 Product Portfolio
    • 8.3.4 Business Strategies
    • 8.3.5 Recent Developments
  • 8.4 Futuremed America, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Overview
    • 8.4.3 Product Portfolio
    • 8.4.4 Business Strategies
  • 8.5 GE Healthcare
    • 8.5.1 Company Overview
    • 8.5.2 Financial Overview
    • 8.5.3 Product Portfolio
    • 8.5.4 Business Strategies
    • 8.5.5 Recent Developments
  • 8.6 MGC Diagnostics Corporation
    • 8.6.1 Company Overview
    • 8.6.2 Financial Overview
    • 8.6.3 Product Portfolio
    • 8.6.4 Business Strategies
    • 8.6.5 Recent Developments
  • 8.7 ndd Medical Technologies, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Overview
    • 8.7.3 Product Portfolio
    • 8.7.4 Business Strategies
    • 8.7.5 Recent Developments
  • 8.8 NIHON KOHDEN CORPORATION
    • 8.8.1 Company Overview
    • 8.8.2 Financial Overview
    • 8.8.3 Product Portfolio
    • 8.8.4 Business Strategies
    • 8.8.5 Recent Developments
    • 8.9 Perkin Elmer, Inc.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Overview
    • 8.9.3 Product Portfolio
    • 8.9.4 Business Strategies
    • 8.9.5 Recent Developments
    • 8.10 Philips Healthcare
    • 8.10.1 Company Overview
    • 8.10.2 Financial Overview
    • 8.10.3 Product Portfolio
    • 8.10.4 Business Strategies
    • 8.10.5 Recent Developments
    • 8.11 SDI Diagnostics
    • 8.11.1 Company Overview
    • 8.11.2 Financial Overview
    • 8.11.3 Product Portfolio
    • 8.11.4 Business Strategies
    • 8.12 Siemens Healthcare
    • 8.12.1 Company Overview
    • 8.12.2 Financial Overview
    • 8.12.3 Product Portfolio
    • 8.12.4 Business Strategies
    • 8.12.5 Recent Developments
    • 8.13 Smiths Medical
    • 8.13.1 Company Overview
    • 8.13.2 Financial Overview
    • 8.13.3 Product Portfolio
    • 8.13.4 Business Strategies
    • 8.13.5 Recent Developments

List of Figures

  • FIG. 1 Respiratory Disease Testing : Market Segmentation
  • FIG. 2 Global Respiratory Disease Testing Market, by Tests, 2013 (USD Million)
  • FIG. 3 Comparative Analysis: Global Respiratory Disease Testing Market, by Geography, 2013 & 2022 (Value %)
  • FIG. 4 Value Chain Analysis of the Respiratory Disease Testing Market
  • FIG. 5 Porter's Five Forces Analysis: Global Respiratory Disease Testing Market
  • FIG. 6 Market Attractiveness Analysis: Global Respiratory Disease Testing Market, by Geography, 2013 Value (%)
  • FIG. 7 Market Share Analysis, by Key Players: Global Respiratory Disease Testing Market, 2013 (Value %)
  • FIG. 8 Global Imaging Test Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 9 Global Spirometry Test Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 10 Global Peak Flow Test Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 11 Global Blood Gas Test Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 12 Global Lung Volume Test Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 13 Global Other Tests Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 14 Global Hospitals End-User Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 15 Global Physician Offices End-User Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 16 Global Clinical laboratories End-User Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 17 U.S. Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 18 Canada Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 19 U.K. Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 20 Germany Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 21 Rest of Europe Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 22 Japan Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 23 China Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 24 Rest of APAC Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 25 Brazil Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 26 Mexico Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 27 Rest of LATAM Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 28 Saudi Arabia Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 29 UAE Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 30 Rest of MENA Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 31 Rest of the World Respiratory Disease Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 32 CareFusion Corporation: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 33 Carestream Health, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 34 GE Healthcare: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 35 MGC Diagnostic Corporation: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 36 NIHON KOHDEN CORPORATION: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 37 PerkinElmer Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 38 Philips Healthcare: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 39 Siemens Healthcare: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 40 Smiths Medical: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 List of Abbreviations
  • TABLE 2 Market Snapshot: Global Respiratory Disease Testing Market (2013 & 2022)
  • TABLE 3 Global Respiratory Disease Testing Market Revenue, by Tests, 2012 - 2022 (USD Million)
  • TABLE 4 Global Respiratory Disease Testing Market Revenue, by End-User, 2012 - 2022 (USD Million)
  • TABLE 5 Global Respiratory Disease Testing Market Revenue, by Geography, 2012 - 2022 (USD Million)
  • TABLE 6 North America Respiratory Disease Testing Market Revenue, by Country, 2012 - 2022 (USD Million)
  • TABLE 7 Europe Respiratory Disease Testing Market Revenue, by Country, 2012 - 2022 (USD Million)
  • TABLE 8 Asia Pacific Respiratory Disease Testing Market Revenue, by Country, 2012 - 2022 (USD Million)
  • TABLE 9 Latin America Respiratory Disease Testing Market Revenue, by Country, 2012 - 2022 (USD Million)
  • TABLE 10 Middle East North Africa Respiratory Disease Testing Market Revenue, by Country, 2012 - 2022 (USD Million)
Back to Top